Shugan Jieyu capsule effects on peripheral blood micro-124, micro-132, and brain-derived neurotrophic factor in patients with mild to moderate depression

Table 7 Comparison of lymphocyte subgroup indicators between the two groups (mean ± SD, n = 30)

Group	Experimental	Control	t	P value
CD3+T cells
Before treatment	53.45 ± 4.56	52.13 ± 5.11	0.924	0.568
After treatment	69.89 ± 5.03a,b	58.32 ± 5.25a	4.857	0.012
CD3+CD4+Th cells
Before treatment	29.23 ± 3.28	28.65 ± 3.42	0.874	0.646
After treatment	40.05 ± 3.96a,b	32.35 ± 4.17a	5.231	0.009
CD3+CD8+CTL cells
Before treatment	25.34 ± 2.92	26.76 ± 2.87	0.922	0.0324
After treatment	20.19 ± 3.18	24.24 ± 3.62	0.845	0.425
CD3-CD19+B cells
Before treatment	14.85 ± 2.33	12.56 ± 2.12	0.984	0.266
After treatment	10.63 ± 2.96	15.32 ± 3.33	1.011	0.123
CD3-CD56+16+NK cells
Before treatment	11.45 ± 2.91	12.77 ± 3.04	0.651	0.758
After treatment	15.66 ± 3.05a	13.46 ± 3.12	3.864	0.011

^aP < 0.05, compared to before treatment within the same group.

^bP < 0.05, compared to the control group.

Th: T helper; NK: Natural killer.